The FDA clinical hold keeps Neumora Therapeutics from catching up to the field of biopharmaceutical companies pursuing the same target for schizophrenia. But Neumora remains on track with its lead ...

William P. Shutze, MD, is a board certified vascular surgeon with Texas Vascular Associates in Dallas. He earned his medical degree from Baylor College of Medicine and completed his general ...

Merith Basey, executive director of Patients For Affordable Drugs, believes the Medicare price negotiation program is here to stay, no matter who is president and no matter how many Big Pharma ...

Form Health launched a new program for people who are overweight that includes meetings with a registered dietitian and a personalized care plan. 3D medical animation services have emerged as a ...

In this month’s episode, Senior Reporter Katie Adams discussed some of the executive moves, exits and layoffs that occurred recently in the healthcare sector. She also interviewed Claire ...

Amazon’s health benefits program continues to expand. Amazon customers eligible for Teladoc Health’s services in diabetes, hypertension, pre-diabetes and weight management can now enroll ...

Last year’s M&A activity in the healthcare sector signaled an unsteady financial recovery for the nation’s hospitals, according to a new report from Kaufman Hall. The report found that there ...

or managing provider and staff workloads are informed by the metrics a physician practice tracks. A new report from Relatient offers a checklist designed to help healthcare organizations optimize ...

INVEST is the flagship event for MedCity News, bringing together healthcare and life science investors, startups and stakeholders in one venue to network and talk about innovations shaping the ...

Imagine a patient with breast cancer, who’s been prescribed a standard chemotherapy treatment. The patient completes the treatment only to find out the cancer is still spreading. Upon further ...

A blockbuster AstraZeneca drug may now be used as an earlier treatment for mantle cell lymphoma (MCL), making it the first in its class approved as a first-line therapy for this rare and ...

With mandatory Alternative Payment Model Performance Pathway (APP) Reporting beginning in Performance Year 2025, the time to act is now. Reporting quality on all beneficiaries marks a major shift ...